{ 26件 }
Usui J, Kawashima S, Sada K, Miyawaki Y, Nakazawa D,.. Narita I, et al.
A digest of the evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 2020.
Clin Exp Nephrol. 2021 Sep 26. doi: 10.1007/s10157-021-02096-7.
IF: 2.8
令和2年度北海道大学医学部エクセレント・ティーチャー（優秀賞） 中沢 大悟先生
Nakazawa D and Kudo T.
Novel Therapeutic Strategy Based on Neutrophil Subset and Its Function in Autoimmune Disease.
Front. Pharmacol, 07 June 2021 https://doi.org/10.3389/fphar.2021.684886
IF; 4.225
Anders HJ and Nakazawa D
'Being an ADVOCATE for People with ANCA Vasculitis’
Clinical Journal of the American Society of Nephrology, in press.
IF: 6.628
Watanabe-Kusunoki K, Kato M, Oki Y, Shimizu T, Kusunoki Y, Furukawa S, Furukawa S, Kitagawa H, Sakai K.
Parallel disease activity of Behçet’s disease with renal and entero
involvements: A case report.
BMC Nephrology. in press.
Watanabe-Kusunoki K, Nakazawa D, Ishizu A, Atsumi T. Thrombomodulin as a physiological modulator of intravascular injury. Frontiers in Immunology (in press)
IF：5.085 (2019)
Nakazawa D and Ishizu A.
Immunothrombosis in Severe COVID-19.
EBioMedicine. in press
IF 6.490
Watanabe-Kusunoki K, Nakazawa D, Kusunoki Y, Kudo T, Hattanda F, Nishio S, Masuda S, Tomaru U, Kondo T, Atsumi T, Ishizu A.
Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection.
Journal of Autoimmunity. 2019. PMID: 31883830